Europe Spinal Muscular Atrophy Market and Competitive Landscape - 2017

  • ID: 4377709
  • Report
  • Region: Europe
  • Fore Pharma
1 of 3
The latest research, Europe Spinal Muscular Atrophy Market and Competitive Landscape - 2017, provides comprehensive insights into Spinal Muscular Atrophy pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Spinal Muscular Atrophy market size and drug sales. This research also provides insights into Spinal Muscular Atrophy epidemiology and late stage pipeline.

The report is classified into nine sections - Spinal Muscular Atrophy overview with definitions, symptoms, etiology, diagnosis, treatment options; Spinal Muscular Atrophy pipeline insights covering late stage clinical trials pipeline; Spinal Muscular Atrophy prevalence trends by countries; Spinal Muscular Atrophy market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Research Scope:
  • Spinal Muscular Atrophy pipeline: Find out the drugs in clinical trials for Spinal Muscular Atrophy by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Spinal Muscular Atrophy epidemiology: Find out the prevalence of Spinal Muscular Atrophy by countries - Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Spinal Muscular Atrophy products: Identify key products marketed and prescribed for Spinal Muscular Atrophy by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Spinal Muscular Atrophy market size: Find out the market size for Spinal Muscular Atrophy drugs by countries - Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Spinal Muscular Atrophy drug sales: Find out the sales of Spinal Muscular Atrophy drugs by countries - Europe, Germany, France, Italy, Spain, UK
  • Spinal Muscular Atrophy drugs sales forecast: Sales forecast for Spinal Muscular Atrophy drugs to 2021 by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Spinal Muscular Atrophy market share analysis: Find out the market shares of Spinal Muscular Atrophy drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Spinal Muscular Atrophy drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Spinal Muscular Atrophy market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Spinal Muscular Atrophy market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Spinal Muscular Atrophy: Disease Overview
1.1. Spinal Muscular Atrophy Symptoms
1.2. Spinal Muscular Atrophy Etiology
1.3. Spinal Muscular Atrophy Diagnosis
1.4. Spinal Muscular Atrophy Treatment Options

2. Spinal Muscular Atrophy Pipeline Insights
2.1. Spinal Muscular Atrophy Phase 3 Clinical Trials
2.2. Spinal Muscular Atrophy Phase 2 Clinical Trials
2.3. Spinal Muscular Atrophy Phase 1 Clinical Trials

3. Spinal Muscular Atrophy Epidemiology Analysis

4. Germany Spinal Muscular Atrophy Market Insights
4.1. Marketed Products for Spinal Muscular Atrophy in Germany
4.2. Germany Spinal Muscular Atrophy Market Size & Forecast
4.3. Germany Spinal Muscular Atrophy Product Sales Forecast
4.4. Germany Spinal Muscular Atrophy Market Share Analysis

5. France Spinal Muscular Atrophy Market Insights
5.1. Marketed Products for Spinal Muscular Atrophy in France
5.2. France Spinal Muscular Atrophy Market Size & Forecast
5.3. France Spinal Muscular Atrophy Product Sales Forecast
5.4. France Spinal Muscular Atrophy Market Share Analysis

6. Italy Spinal Muscular Atrophy Market Insights
6.1. Marketed Products for Spinal Muscular Atrophy in Italy
6.2. Italy Spinal Muscular Atrophy Market Size & Forecast
6.3. Italy Spinal Muscular Atrophy Product Sales Forecast
6.4. Italy Spinal Muscular Atrophy Market Share Analysis

7. Spain Spinal Muscular Atrophy Market Insights
7.1. Marketed Products for Spinal Muscular Atrophy in Spain
7.2. Spain Spinal Muscular Atrophy Market Size & Forecast
7.3. Spain Spinal Muscular Atrophy Product Sales Forecast
7.4. Spain Spinal Muscular Atrophy Market Share Analysis

8. UK Spinal Muscular Atrophy Market Insights
8.1. Marketed Products for Spinal Muscular Atrophy in UK
8.2. UK Spinal Muscular Atrophy Market Size & Forecast
8.3. UK Spinal Muscular Atrophy Product Sales Forecast
8.4. UK Spinal Muscular Atrophy Market Share Analysis

9. Europe Spinal Muscular Atrophy Market Insights
9.1. Europe Spinal Muscular Atrophy Market Size & Forecast
9.2. Europe Spinal Muscular Atrophy Product Sales Forecast
9.3. Europe Spinal Muscular Atrophy Market Share Analysis

10. Research Methodology

List of Tables:
Table 1: Spinal Muscular Atrophy Phase 3 Clinical Trials, Global, 2017
Table 2: Spinal Muscular Atrophy Phase 2 Clinical Trials, Global, 2017
Table 3: Spinal Muscular Atrophy Phase 1 Clinical Trials, Global, 2017
Table 4: Spinal Muscular Atrophy Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Spinal Muscular Atrophy in Germany, 2017
Table 6: Germany Spinal Muscular Atrophy Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Spinal Muscular Atrophy Product Sales ($mn), 2012 - 2021
Table 8: Germany Spinal Muscular Atrophy Market Trends, 2012 - 2021
Table 9: Marketed Products for Spinal Muscular Atrophy in France, 2017
Table 10: France Spinal Muscular Atrophy Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Spinal Muscular Atrophy Product Sales ($mn), 2012 - 2021
Table 12: France Spinal Muscular Atrophy Market Trends, 2012 - 2021
Table 13: Marketed Products for Spinal Muscular Atrophy in Italy, 2017
Table 14: Italy Spinal Muscular Atrophy Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Spinal Muscular Atrophy Product Sales ($mn), 2012 - 2021
Table 16: Italy Spinal Muscular Atrophy Market Trends, 2012 - 2021
Table 17: Marketed Products for Spinal Muscular Atrophy in Spain, 2017
Table 18: Spain Spinal Muscular Atrophy Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Spinal Muscular Atrophy Product Sales ($mn), 2012 - 2021
Table 20: Spain Spinal Muscular Atrophy Market Trends, 2012 - 2021
Table 21: Marketed Products for Spinal Muscular Atrophy in UK, 2017
Table 22: UK Spinal Muscular Atrophy Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Spinal Muscular Atrophy Product Sales ($mn), 2012 - 2021
Table 24: UK Spinal Muscular Atrophy Market Trends, 2012 - 2021
Table 25: Europe Spinal Muscular Atrophy Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Spinal Muscular Atrophy Product Sales ($mn), 2012 - 2021

List of Figures:
Figure 1: Spinal Muscular Atrophy Pipeline by Phase (%), Global, 2017
Figure 2: Spinal Muscular Atrophy Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Spinal Muscular Atrophy Market Size ($mn), 2012 - 2021
Figure 4: Germany Spinal Muscular Atrophy Product Sales ($mn), 2012 - 2021
Figure 5: Germany Spinal Muscular Atrophy Market Share by Products (%), 2016
Figure 6: Germany Spinal Muscular Atrophy Market - Future Market Share (%), 2021
Figure 7: France Spinal Muscular Atrophy Market Size ($mn), 2012 - 2021
Figure 8: France Spinal Muscular Atrophy Product Sales ($mn), 2012 - 2021
Figure 9: France Spinal Muscular Atrophy Market Share by Products (%), 2016
Figure 10: France Spinal Muscular Atrophy Market - Future Market Share (%), 2021
Figure 11: Italy Spinal Muscular Atrophy Market Size ($mn), 2012 - 2021
Figure 12: Italy Spinal Muscular Atrophy Product Sales ($mn), 2012 - 2021
Figure 13: Italy Spinal Muscular Atrophy Market Share by Products (%), 2016
Figure 14: Italy Spinal Muscular Atrophy Market - Future Market Share (%), 2021
Figure 15: Spain Spinal Muscular Atrophy Market Size ($mn), 2012 - 2021
Figure 16: Spain Spinal Muscular Atrophy Product Sales ($mn), 2012 - 2021
Figure 17: Spain Spinal Muscular Atrophy Market Share by Products (%), 2016
Figure 18: Spain Spinal Muscular Atrophy Market - Future Market Share (%), 2021
Figure 19: UK Spinal Muscular Atrophy Market Size ($mn), 2012 - 2021
Figure 20: UK Spinal Muscular Atrophy Product Sales ($mn), 2012 - 2021
Figure 21: UK Spinal Muscular Atrophy Market Share by Products (%), 2016
Figure 22: UK Spinal Muscular Atrophy Market - Future Market Share (%), 2021
Figure 23: Europe Spinal Muscular Atrophy Market Size ($mn), 2012 - 2021
Figure 24: Europe Spinal Muscular Atrophy Product Sales ($mn), 2012 - 2021
Figure 25: Europe Spinal Muscular Atrophy Market Share by Products (%), 2016
Figure 26: Europe Spinal Muscular Atrophy Market - Future Market Share (%), 2021
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll